Aprea Therapeutics (APRE) Stock Price, Quote, News & History

Comments

Aprea Therapeutics Inc (APRE) Stock Price, Quote, News & History

APRENASDAQ

Trade with Public

$0.7561

0.02012.73%

At close: Mar 13, 5:00 PM EST

$0.7590

0.0233.13%

Pre-Market: 7:55 AM EST

Earnings: Q4 2025 Earnings were released on Mon Mar 16th, before the market open

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$0.76

Volume / Avg.

0 / 2.14M

Day Range

- - -

52 Wk Range

0.55 - 2.65

Market Cap

$5.31M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

3.88%

Days to Cover

1

Recent Aprea Therapeutics Inc News

PRO
Aprea Therapeutics Q4 EPS $(0.32) Misses $(0.30) Estimate, Sales $3.337K Down From $205.817K YoY

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.30) by 5.61 percent. This is a 34.69 percent increase over losses of $(0.49) per share

Benzinga Newsdesk

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga Insights

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga Insights

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-13.44M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

933.07K

Free Cash Flow (TTM)

-13.44M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-12.51M

Analyst Trends and Forecast

1

Dec 25

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$5.06M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.79

Earnings Yield % (TTM)

-280.39%

Earnings Yield % (FWD)

-174.58%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.95

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$13.72M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$0.76

Volume / Avg.

0 / 2.14M

Day Range

- - -

52 Wk Range

0.55 - 2.65

Market Cap

$5.31M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

3.88%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for sol...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Aprea Therapeutics (APRE) stock?

A

You can purchase shares of Aprea Therapeutics (NASDAQ:APRE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aprea Therapeutics (APRE) competitors?

A

Other companies in Aprea Therapeutics’s space includes: Immuron Ltd (NASDAQ:IMRN), Lunai Bioworks Inc (NASDAQ:LNAI), Can Fite Biopharma Ltd (AMEX:CANF), BioRestorative Therapies Inc (NASDAQ:BRTX) and AIxCrypto Holdings Inc (NASDAQ:AIXC).

Q

What is the forecast, or price target, for Aprea Therapeutics (APRE) stock?

A

Aprea Therapeutics has a consensus price target of $5.50.

Q

What is the current price for Aprea Therapeutics (APRE)?

A

The stock price for Aprea Therapeutics (NASDAQ: APRE) is $0.759 last updated March 16, 2026 at 7:35 PM EDT.

Q

Does Aprea Therapeutics (APRE) pay a dividend?

A

There are no upcoming dividends for Aprea Therapeutics.

Q

When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?

A

Aprea Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aprea Therapeutics (APRE) going to split?

A

There is no upcoming split for Aprea Therapeutics.

Q

What sector and industry does Aprea Therapeutics (APRE) operate in?

A

Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

CANF

BioRestorative Therapies Inc

NASDAQ:BRTX

$0.28

-2.82%

AIxCrypto Holdings Inc

Indaptus Therapeutics Inc

Key Statistics

Open

-

Close

$0.76

Volume / Avg.

0 / 2.14M

Day Range

- - -

52 Wk Range

0.55 - 2.65

Market Cap

$5.31M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

3.88%

Days to Cover

1

Recent Aprea Therapeutics Inc News

PRO
Aprea Therapeutics Q4 EPS $(0.32) Misses $(0.30) Estimate, Sales $3.337K Down From $205.817K YoY

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.30) by 5.61 percent. This is a 34.69 percent increase over losses of $(0.49) per share

Benzinga Newsdesk

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga Insights

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga Insights

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-13.44M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

933.07K

Free Cash Flow (TTM)

-13.44M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-12.51M

Analyst Trends and Forecast

1

Dec 25

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$5.06M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.79

Earnings Yield % (TTM)

-280.39%

Earnings Yield % (FWD)

-174.58%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.95

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$13.72M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$0.76

Volume / Avg.

0 / 2.14M

Day Range

- - -

52 Wk Range

0.55 - 2.65

Market Cap

$5.31M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

3.88%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for sol...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry